Preadmission use of benzodiazepines and stroke outcomes: the Biostroke prospective cohort study
Olivier Colin, Julien Labreuche, Julie Deguil, Anne-Marie Mendyk, Valérie Deken, Charlotte Cordonnier, Dominique Deplanque, Didier Leys, Régis Bordet, Olivier Colin, Julien Labreuche, Julie Deguil, Anne-Marie Mendyk, Valérie Deken, Charlotte Cordonnier, Dominique Deplanque, Didier Leys, Régis Bordet
Abstract
Objectives: We tested the hypothesis that stroke outcomes in patients with preadmission use of benzodiazepine are worse.
Method: In a prospective cohort study, we recruited patients with acute ischaemic stroke. Mortality, functional outcomes and cognition were evaluated at 8 and 90 days after stroke.
Results: 370 patients were included. 62 (18.5%) of the 336 remaining patients were treated with benzodiazepines when stroke occurred, and they did not receive any other psychotropic drug. The mortality rate was higher in benzodiazepines users than non-users at day 8 (2.2% vs 8.1%, p=0.034) and day 90 (8.1% vs 25.9%, p=0.0001). After controlling for baseline differences using propensity-score matching, only the difference in mortality rate at day 90 was of borderline of significance, with a matched OR of 3.93 (95% CI, 0.91 to 16.98). In propensity-score-adjusted cohort, this difference remained significant with a similar treatment effect size (adjusted OR, 3.50; 95% CI, 1.57 to 7.76). A higher rate of poor functional outcome at day 8 and day 90 defined bymodified Rankin scale (mRS) ≥2 or by theBarthel index (BI) <95 was found in benzodiazepines users. In propensity-score-adjusted cohort, only the difference in mRS≥2 at day 90 remained significant (adjusted OR, 1.89; 95% CI, 1.02 to 3.48). In survivors at day 8 and at day 90, there was no significant difference in cognitive evaluation.
Conclusion: Our study has shown that preadmission use of benzodiazepines could be associated with increased post-stroke mortality at 90 days. These findings do not support a putative neuroprotective effect of γ-aminobutyric acidA receptors agonists and should alert clinicians of their potential risks.
Trial registration number: NCT00763217.
Keywords: benzodiazepines; mortality; stroke.
Conflict of interest statement
Competing interests: None declared.
© Author(s) (or their employer(s)) 2019. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Figures
References
- Lozano R, Naghavi M, Foreman K, et al. . Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the global burden of disease study 2010. Lancet 2012;380:2095–128. 10.1016/S0140-6736(12)61728-0
- Deplanque D, Masse I, Lefebvre C, et al. . Prior TIA, lipid-lowering drug use, and physical activity decrease ischemic stroke severity. Neurology 2006;67:1403–10. 10.1212/01.wnl.0000240057.71766.71
- Marshall JW, Green AR, Ridley RM. Comparison of the neuroprotective effect of clomethiazole, AR-R15896AR and NXY-059 in a primate model of stroke using histological and behavioural measures. Brain Res 2003;972:119–26. 10.1016/S0006-8993(03)02511-3
- Nelson RM, Green AR, Lambert DG, et al. . On the regulation of ischaemia-induced glutamate efflux from rat cortex by GABA; in vitro studies with GABA, clomethiazole and pentobarbitone. Br J Pharmacol 2000;130:1124–30. 10.1038/sj.bjp.0703398
- Liu J, Wang LN. Gamma aminobutyric acid (GABA) receptor agonists for acute stroke. Cochrane Database Syst Rev 2013;2:CD009622 10.1002/14651858.CD009622.pub2
- Ducroquet A, Leys D, Al Saabi A, et al. . Influence of chronic ethanol consumption on the neurological severity in patients with acute cerebral ischemia. Stroke 2013;44:2324–6. 10.1161/STROKEAHA.113.001355
- Austin PC. An introduction to propensity score methods for reducing the effects of confounding in observational studies. Multivariate Behav Res 2011;46:399–424. 10.1080/00273171.2011.568786
- Austin PC. A comparison of 12 algorithms for matching on the propensity score. Stat Med 2014;33:1057–69. 10.1002/sim.6004
- Austin PC. Optimal caliper widths for propensity-score matching when estimating differences in means and differences in proportions in observational studies. Pharm Stat 2011;10:150–61. 10.1002/pst.433
- Austin PC. Balance diagnostics for comparing the distribution of baseline covariates between treatment groups in propensity-score matched samples. Stat Med 2009;28:3083–107. 10.1002/sim.3697
- Mattei A. Estimating and using propensity score in presence of missing background data: an application to assess the impact of childbearing on wellbeing. Statistical Methods and Applications 2009;18:257–73. 10.1007/s10260-007-0086-0
- Buuren S, Groothuis-Oudshoorn K. mice : multivariate imputation by chained equations in R . J Stat Softw 2011;45.
- Rubin DB. Multiple imputation for nonresponse in surveys. New York: Wiley, 1987.
- Frank B, Fulton RL, Lees KR, et al. . Impact of benzodiazepines on functional outcome and occurrence of pneumonia in stroke: evidence from VISTA. Int J Stroke 2014;9:890–4. 10.1111/ijs.12148
- Weich S, Pearce HL, Croft P, et al. . Effect of anxiolytic and hypnotic drug prescriptions on mortality hazards: retrospective cohort study. BMJ 2014;348:g1996 10.1136/bmj.g1996
- Palmaro A, Dupouy J, Lapeyre-Mestre M. Benzodiazepines and risk of death: Results from two large cohort studies in France and UK. Eur Neuropsychopharmacol 2015;25:1566–77. 10.1016/j.euroneuro.2015.07.006
- Jennum P, Baandrup L, Iversen HK, et al. . Mortality and use of psychotropic medication in patients with stroke: a population-wide, register-based study. BMJ Open 2016;6:e010662 10.1136/bmjopen-2015-010662
- Wu CK, Huang YT, Lee JK, et al. . Anti-anxiety drugs use and cardiovascular outcomes in patients with myocardial infarction: a national wide assessment. Atherosclerosis 2014;235:496–502. 10.1016/j.atherosclerosis.2014.05.918
- Obiora E, Hubbard R, Sanders RD, et al. . The impact of benzodiazepines on occurrence of pneumonia and mortality from pneumonia: a nested case-control and survival analysis in a population-based cohort. Thorax 2013;68:163–70. 10.1136/thoraxjnl-2012-202374
- Billioti de Gage S, Bégaud B, Bazin F, et al. . Benzodiazepine use and risk of dementia: prospective population based study. BMJ 2012;345:e6231 10.1136/bmj.e6231
- Airagnes G, Pelissolo A, Lavallée M, et al. . Benzodiazepine misuse in the elderly: risk factors, consequences, and management. Curr Psychiatry Rep 2016;18:89 10.1007/s11920-016-0727-9
- House A, Knapp P, Bamford J, et al. . Mortality at 12 and 24 months after stroke may be associated with depressive symptoms at 1 month. Stroke 2001;32:696–701. 10.1161/01.STR.32.3.696
- Forster A, Juge O, Morel D. Effects of midazolam on cerebral blood flow in human volunteers. Anesthesiology 1982;56:453–5. 10.1097/00000542-198206000-00009
- Bartlett E, Mikulis DJ. Chasing "chasing the dragon" with MRI: leukoencephalopathy in drug abuse. Br J Radiol 2005;78:997–1004. 10.1259/bjr/61535842
Source: PubMed